Inozyme Pharma Inc (INZY) Annual Balance Sheets

Annual · GAAP · USD millions
Access INZY quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Inozyme Pharma Inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent21.08
Short-term Investments, Total92.01
Cash & Short-term Investments113.00
Other Current Assets0.31
Prepaid Expense And Other Assets Current7.28
Total Current Assets120.68
Equipment/Property/Plant Net0.78
Long-term investments0.00
Prepaid Expense, Noncurrent, Total PR1.16
Other Assets, Noncurrent0.56
Restricted Cash0.31
Restricted Cash Noncurrent-
Total Assets123.18
Liabilities
Accounts Payable, Current AC2.53
Accrued Liabilities, Current AC15.95
Other Liabilities, Current15.42
Total Current Liabilities33.90
Long-term debt31.46
Total Long-term Debt31.46
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.91
Total Liabilities65.36
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock445.71
Retained Earnings / Accumulated Deficit-387.95
Other Equity0.07
Common Stockholder's Equity57.83
Total Stockholder's Equity57.83
Liabilities & Stockholder's Equity123.18
4 historic quarters locked

Sign in to unlock the full Inozyme Pharma Inc balance sheet history.

About Inozyme Pharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-035940

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License